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Background
As a precursor to overt heart failure, diabetics experi-
ence a unique alteration in myocardial architecture
marked by diffuse interstitial fibrosis. We hypothesized
that the myocardial extracellular volume fraction
(MECVF) could be used to detect myocardial matrix
remodeling and its relationship to ventricular structure
and function in diabetics without cardiovascular disease.
Methods
Diabetics without any history of MI (by clinical grounds
or by evidence of subendocardial LGE) or heart failure
underwent 3T CMR imaging and assessment of MECVF
and assessment of biochemical parameters of insulin sen-
sitivity. 10 volunteers without diabetes, hypertension, or
clinical cardiac disease were used for comparison. Cine
SSFP, LGE imaging, and myocardial T1 quantitation
using a modified Look-Locker sequence were performed.
For measurement of MECVF, segmental myocardial T1
was measured once pre-Gd and at least 3 times over 3-20
minutes post-Gd (gadopentetate dimeglumine, 0.15
mmol/kg). Regression of myocardial R1 (=1/T1) on R1 in
the blood pool was used to determine the Gd partition
coefficient, which when multiplied by (1-hematocrit/
100), gave MECVF. Left atrial volume index (LAVI) and
emptying function, as well as LV and RV volumes and
function, were determined by standard techniques.
Results
55 recruited patients were predominantly male (62%),
with an average age of 54±8 years, systolic blood pres-
sure 126±14 mmHg, body mass index (BMI) 32.4±4 kg/
m2, fasting glucose 108±25 mg/dl, and triglycerides 128
±69 mg/dl. CMR LVEF averaged 60±5%, LV mass index
45±11 g/m2, LVEDV index 68±14 ml/m2, LAVI 35±9
ml/ m2 (assessed in 38 patients; all values in normal
range). MECVF in diabetics was 0.36±0.05 (as compared
to normal controls 0.29±0.04, P = .0004 by unpaired t-
test). MECVF correlated with LAVI (r =0.34; p = 0.04),
but not with LV mass index, fasting glucose or insulin
levels, insulin sensitivity, triglycerides, LVEF, age, BMI,
LA function or systolic blood pressure.
Conclusions
Well-controlled diabetics with normal ventricular struc-
ture, function, and no prior cardiac disease have diffuse
interstitial myocardial fibrosis by CMR. Diffuse fibrosis
is associated with LAVI, a marker of diastolic function,
but not with other markers of clinical or cardio-meta-
bolic risk. Diffuse myocardial damage occurs early in the
course of diabetic cardiomyopathy independent of
hypertension and obesity, and may be a potential target
for early intervention in at-risk diabetic patients with
subclinical myocardial disease.
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